UroGen Pharma (0XOD.LSE) Q4 2023 Earnings

Mar 14Confirmed
Q4 2023
-0.72
-0.71
-0.69
-0.68

Details

Expected EPS
-0.68
Actual EPS
-0.72
Surprise EPS
-0.04
Surprise Percent
-5.88%

Description

⁨UroGen Pharma⁩ (⁦0XOD.LSE⁩) has reported earnings of ⁦-0.72⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts